These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27258622)

  • 1. Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer.
    Mohyeldin MM; Busnena BA; Akl MR; Dragoi AM; Cardelli JA; El Sayed KA
    Eur J Med Chem; 2016 Aug; 118():299-315. PubMed ID: 27258622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor.
    Mohyeldin MM; Akl MR; Ebrahim HY; Dragoi AM; Dykes S; Cardelli JA; El Sayed KA
    Oncotarget; 2016 May; 7(22):32247-73. PubMed ID: 27086914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olive secoiridoids and semisynthetic bioisostere analogues for the control of metastatic breast cancer.
    Busnena BA; Foudah AI; Melancon T; El Sayed KA
    Bioorg Med Chem; 2013 Apr; 21(7):2117-27. PubMed ID: 23403296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models.
    Akl MR; Ayoub NM; Mohyeldin MM; Busnena BA; Foudah AI; Liu YY; Sayed KA
    PLoS One; 2014; 9(5):e97622. PubMed ID: 24849787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies.
    Ebrahim HY; Mohyeldin MM; Hailat MM; El Sayed KA
    Bioorg Med Chem; 2016 Nov; 24(22):5748-5761. PubMed ID: 27681240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
    Mady MS; Mohyeldin MM; Ebrahim HY; Elsayed HE; Houssen WE; Haggag EG; Soliman RF; El Sayed KA
    Bioorg Med Chem; 2016 Jan; 24(2):113-22. PubMed ID: 26692349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers.
    Elnagar AY; Sylvester PW; El Sayed KA
    Planta Med; 2011 Jul; 77(10):1013-9. PubMed ID: 21328179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
    Foudah AI; Sallam AA; Akl MR; El Sayed KA
    Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo.
    Siddique AB; Ebrahim HY; Akl MR; Ayoub NM; Goda AA; Mohyeldin MM; Nagumalli SK; Hananeh WM; Liu YY; Meyer SA; El Sayed KA
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 13
    Souid S; Elsayed HE; Ebrahim HY; Mohyeldin MM; Siddique AB; Karoui H; El Sayed KA; Essafi-Benkhadir K
    Mol Carcinog; 2018 Nov; 57(11):1507-1524. PubMed ID: 29978911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
    Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
    Int J Oncol; 2009 Jan; 34(1):43-51. PubMed ID: 19082476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling.
    Parr C; Ali AY
    J Transl Med; 2018 Oct; 16(1):281. PubMed ID: 30314527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
    Elsayed HE; Ebrahim HY; Haggag EG; Kamal AM; El Sayed KA
    Bioorg Med Chem; 2017 Dec; 25(24):6297-6312. PubMed ID: 29066046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer.
    Siddique AB; Kilgore PCSR; Tajmim A; Singh SS; Meyer SA; Jois SD; Cvek U; Trutschl M; Sayed KAE
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norstictic Acid Inhibits Breast Cancer Cell Proliferation, Migration, Invasion, and In Vivo Invasive Growth Through Targeting C-Met.
    Ebrahim HY; Elsayed HE; Mohyeldin MM; Akl MR; Bhattacharjee J; Egbert S; El Sayed KA
    Phytother Res; 2016 Apr; 30(4):557-66. PubMed ID: 26744260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3,4-dihydropyrimidin-2(1H)-one C5 amide derivatives.
    Moosavi F; Ebadi A; Mohabbati M; Damghani T; Mortazavi M; Miri R; Firuzi O
    Eur J Pharmacol; 2021 Mar; 894():173850. PubMed ID: 33428899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
    Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
    Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer.
    Sylvester PW
    Clin Transl Med; 2014 Dec; 3(1):30. PubMed ID: 26932375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies.
    Elsayed HE; Ebrahim HY; Mohyeldin MM; Siddique AB; Kamal AM; Haggag EG; El Sayed KA
    Nutr Cancer; 2017; 69(8):1256-1271. PubMed ID: 29083228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
    Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
    Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.